Firm

Newsweek review of financial filings in Congress has found that lawmakers who are driving legislation to protect Uyghurs in China are also invested—either directly in the form of stocks, or indirectly via mutual funds—in major companies tied to the oppression in Xinjiang.

Pfizer is about to buy Arena Pharmaceuticals for $6.7 billion. Arena is a biopharmaceutical company focused in part on cardiovascular and inflammatory medicines to a global patient cohort.

Special Counsel John Durham is investigating multiple former members of Hillary Clinton’s 2016 campaign.

An offshore drilling ban in the United States would strengthen oil-rich countries like Russia, experts say.

LAUSD to push back deadline for student Covid-19 vaccinations to fall 2022.

The world's biggest asset manager issues a new policy update, which stresses decarbonization and board member diversity.

Texas Gov. Greg Abbott unveiled the first section of the state's new border wall, while also blasting President Joe Biden for not doing his part in securing the southern border.

Amid concerns about Beijing's use of emerging technologies, the administration adds China's top military medical research institute to an export blacklist.

Two Republican candidates in Nevada’s gubernatorial race are leading over Democrat incumbent Gov. Steve Sisolak in hypothetical match-ups.

It is time for Christians to acknowledge that modern Christianity has been badly damaged by the pagan values of the Enlightenment.